AI Accelerating Rare Disease Drug Discovery Programs

The pharmaceutical sector is currently witnessing a fundamental shift in how orphan drugs are identified and moved through the clinical pipeline. For decades, the primary challenge for researchers has been the sheer scarcity of patient data and the immense biological complexity inherent in thousands of distinct rare conditions. Traditional methods of drug development often failed […] The post AI Accelerating Rare Disease Drug Discovery Programs first appeared on World Pharma Today .

Source: Read Full Article